You just read:

Valeant Pharmaceuticals Announces Redemption Of The Remaining $465.5 Million Aggrerate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016

News provided by

Valeant Pharmaceuticals International, Inc.

Dec 02, 2013, 17:00 ET